Buy for April 8th 2008

Buy Sun Pharmaceutical Industries Ltd. at 1260. stop loss 1190.
target price 1450 in 3 months.

Recent news:

Sun Pharmaceutical Industries Ltd on March 31, 2008, has announced that it has commercially launched generic Amifostine for Injection 500mg, which is therapeutically equivalent to Medlmmune's Ethyolr. The Company's product is being sold in the United States by its marketing partner Caraco Pharmaceutical Laboratories. The Company had received a USFDA approval for this earlier in March 2008. Ethyoir has annual sales of approximately USD 80 million in the US.

The Company being the first-to-file an ANDA for generic Ethyolr with a pare IV certification, has a 180-day marketing exclusivity.

Ethyolr is covered under 3 patents - '471 (July 31, 2012), '731 (July 31, 2012) and '409 (December 08, 2017). This ANDA was filed with para IV certification against all the patents Medimmune flied a suit in the District Court of Maryland and the case is under litigation.

Source:BSE India

Comments

Popular posts from this blog

Stock Buzz Jan 14th 2010

How OBAMA stimulus bill affects you

Take care of your parents. THEY ARE PRECIOUS.